ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial
Allied Critical Metals Appoints General James A. "Spider" Marks as a Director of Allied Critical Metals USA, Its U.S. Subsidiary Focused on Tungsten Import and Sales
